Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05976672 · ClinicalTrials.gov registry record · NA
Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs
A NA study of Substance Abuse Disorder, sponsored by West Virginia University.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05976672: Active NA study of Substance Abuse Disorder, sponsored by West Virginia University.
NCT05976672 is a NA study of Substance Abuse Disorder that is active but no longer recruiting, run by West Virginia University. The registered enrollment target is 500 participants, above the 132-participant average among 3 other Substance Abuse Disorder trials with a reported enrollment target (279% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05976672, a NA study of Substance Abuse Disorder, is active but no longer recruiting, sponsored by West Virginia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to study the relationship between substance cravings, cognitive performance, behaviors, and physiological markers in individuals with substance use disorder, as well as the effects of peer recovery intervention in response to abnormal biomarker data detected by wearable technology (e.g., Oura ring, smart watch) and participant responses to questionnaires and cognitive tasks completed on the RNI Health application.
Primary Outcome
Beats per minute collected from participant connected wearable device
Conditions Studied
Interventions
- OTHER PRSS (Peer Recovery Support Specialist)
Study Locations (1)
West Virginia
- West Virginia University Rockefeller Neuroscience Institute - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2028-04-26 |
| Phase | NA |
What the registry record for NCT05976672 still lists
NCT05976672 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 3 other Substance Abuse Disorder trials with a reported enrollment target (279% higher).
The record links to 1 condition, with Substance Abuse Disorder appearing as the primary indexed condition, and to 1 intervention - of which PRSS (Peer Recovery Support Specialist) is the first listed.
NCT05976672 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT05976672 about?
NCT05976672 is a clinical study titled "Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs". The goal of this clinical trial is to study the relationship between substance cravings, cognitive performance, behaviors, and physiological markers in individuals with substance use disorder, as well as the effects of peer recovery intervention in response to abnormal biomarker data detected by wea...
What is the current status of trial NCT05976672?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-04-27. Estimated completion is 2028-04-26.
What conditions does trial NCT05976672 study?
This clinical trial studies the following conditions: Substance Abuse Disorder.
What interventions are being tested in trial NCT05976672?
The interventions under investigation include: PRSS (Peer Recovery Support Specialist) (OTHER).
Who is sponsoring clinical trial NCT05976672?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05976672 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI